A phase III multicenter, randomized, controlled study of combined androgen blockade with versus without zoledronic acid in prostate cancer patients with metastatic bone disease: results of the ZAPCA trial
暂无分享,去创建一个
O. Ogawa | S. Egawa | T. Terachi | T. Kamoto | N. Masumori | K. Fujimoto | T. Kamba | S. Namiki | F. Sato | H. Sakai | Y. Shimizu | T. Satoh | S. Narita | M. Sugimoto | J. Teishima | Y. Okada | T. Kikuchi | H. Saito | H. Kawanishi | Shinichiro Maruo | Zapca Study Group